Group items tagged

Canada has always had to fight hard to attract talent and investment

MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.

"We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.

Probably most impressive was The MaRS Centre - an old hospital converted into a non-profit innovation centre connecting science, technology and social entrepreneurs with business skills, networks and capital. The building is undeniably cool. Located in Toronto’s “Discovery District” -- two square kilometres have been designated as the city’s center of innovation. The MaRS Centre is a gateway of sorts to Canada’s largest concentration of scientific research. It’s anchored by major teaching hospitals, the University of Toronto and more than two dozen affiliated research institutes.

MaRS Centre from the outside

MaRS was created in 2000. The founding group raised significant capital (almost $100 million from all three levels of government and both institutional and individual private sector donors and an additional $130 million of debt and credit lease instruments were also secured) to support the development. What’s so clear is that leadership to drive public/private sector collaboration is required to effect real change. Many credit Ontario Premier Dalton McGuinty for helping to not only create the MaRS Centre but also invigorate the region as a whole.

MaRS, a Toronto-based, not-for-profit incubation center, is leading a delegation of five cleantech ventures at this week’s Cleantech Forum XXIII in Boston. The companies – all clients of MaRS advisory services – will showcase their products for the cleantech CEOs, investors, scientists and policy makers attending the east coast forum. “While cleantech is a relatively new sector for MaRS advisory services, it is fast catching up with our other core strengths in information technologies and life sciences,” said Tom Rand, a cleantech entrepreneur, author and investor who leads MaRS’ cleantech practice. “MaRS is establishing itself as a major deal-flow engine in the cleantech sector, with an emphasis on early-stage companies.”

Alternative Fuels

Nimtech